Niagen Bioscience (NAGE) Interest Coverage Ratio (2010 - 2026)
Niagen Bioscience's (NAGE) quarterly Interest Coverage Ratio came in at 3.74 in Q1 2026, up 216.14% year-on-year from 1.18 in Q1 2025, and up 158.27% on a QoQ basis from 6.42 in Q4 2025.
Niagen Bioscience (NAGE) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 17 years of Interest Coverage Ratio data on file, last reported at 3.74 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 216.14% year-over-year to 3.74 in Q1 2026; TTM through Mar 2026 was 31.08, a 846.68% increase from a year earlier, with the FY2025 full-year figure at 0.4, up 130.47% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 3.74, up from 6.42 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for NAGE reached as high as 29.38 in Q4 2024 and fell as low as 15.53 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 0.13 across 5 years, with a median of 0.52 in 2023.
- On a YoY basis, Interest Coverage Ratio climbed as much as 1884.05% in 2024 and fell as far as 256.16% in 2024.
- Year by year, Interest Coverage Ratio stood at 10.7 in 2022, then soared by 84.6% to 1.65 in 2023, then soared by 1884.05% to 29.38 in 2024, then slumped by 121.86% to 6.42 in 2025, then soared by 158.27% to 3.74 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 3.74 in Q1 2026, 6.42 in Q4 2025, and 6.45 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn | 3.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.74 |
| Dec 31, 2025 | -6.42 |
| Sep 30, 2025 | 6.45 |
| Jun 30, 2025 | 0.82 |
| Mar 31, 2025 | 1.18 |
| Dec 31, 2024 | 29.38 |
| Sep 30, 2024 | 0.51 |
| Jun 30, 2024 | -1.04 |
| Mar 31, 2024 | -1.49 |
| Dec 31, 2023 | -1.65 |
| Sep 30, 2023 | -0.27 |
| Jun 30, 2023 | -0.52 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | -10.70 |
| Sep 30, 2022 | -0.61 |
| Jun 30, 2022 | -1.21 |
| Mar 31, 2022 | -15.53 |
| Dec 31, 2021 | 11.29 |
| Sep 30, 2021 | -10.58 |
| Jun 30, 2021 | -1.34 |